Edinburgh and Paris, April 6th, 2016 – Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical

Hamburg, Germany, 22 March 2016 – Topas Therapeutics GmbH (“Topas”), a Hamburg/Germany based company, today announced the closing of its Series A financing round. This

Edinburgh, United Kingdom, 9th March, 2016 – Edinburgh Molecular imaging Ltd (EM Imaging) announced today that the company has received a SBRI Stratified Medicine Connecting the

Louisville, Ky., Feb. 12, 2016 – Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new

By Varun Saxena, FierceMedicalDevices December 10, 2015 – Harpoon Medical Executive Vice President Peter Boyd told FierceMedicalDevices that cardiology titan Edwards Lifesciences acquired an option

By Varun Saxena, FierceMedicalDevices December 9, 2015 – Just as the flurry of M&A activity in the transcatheter mitral valve repair arena appears to be

Glasgow, United Kingdom, November 4th 2015 –  Caldan Therapeutics Ltd (Caldan) has announced a £4.45 million ‘Series A’ investment led by Epidarex Capital, a leading

Outstanding clinical results reported at 2015 Transcatheter Therapeutics Conference in San Francisco. Baltimore, MD, Oct. 15, 2015 – Harpoon Medical, Inc. a medical device company